BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33002235)

  • 1. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis.
    Uchino M; Ikeuchi H; Hata K; Minagawa T; Horio Y; Kuwahara R; Nakamura S; Watanabe K; Saruta M; Fujii T; Kobayashi T; Sugimoto K; Hirai F; Esaki M; Hiraoka S; Matsuoka K; Shinzaki S; Matsuura M; Inoue N; Nakase H; Watanabe M
    J Gastroenterol Hepatol; 2021 Apr; 36(4):864-872. PubMed ID: 33002235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
    Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
    Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.
    Singh S; Garg SK; Pardi DS; Wang Z; Murad MH; Loftus EV
    Gastroenterology; 2015 Jan; 148(1):64-76.e2; quiz e14. PubMed ID: 25263803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis.
    Nguyen DL; Solaimani P; Nguyen ET; Jamal MM; Bechtold ML
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1152-9. PubMed ID: 25089549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
    Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G
    J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
    Burr NE; Hall B; Hamlin PJ; Selinger CP; Ford AC; O'Connor A
    J Crohns Colitis; 2019 May; 13(6):693-701. PubMed ID: 30561586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.
    Zhao Y; Ma T; Chen YF; He XY; Ren LH; Chen J; Fang L; Su JW; Zhang HJ; Shi RH
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):637-49. PubMed ID: 25958300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease: A Systematic Review and Network Meta-Analysis of Prospective Trials.
    Bakouny Z; Yared F; El Rassy E; Jabbour R; Hallit R; Khoury N; Honein K; Bou Jaoude J
    J Clin Gastroenterol; 2019 Jul; 53(6):409-417. PubMed ID: 29517709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence.
    Qiu Y; Mao R; Chen BL; He Y; Zeng ZR; Chen MH
    J Crohns Colitis; 2015 Oct; 9(10):918-27. PubMed ID: 26116553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
    Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta-analysis.
    Jain SR; Ow ZGW; Chin YH; Lim WH; Kong G; Tham HY; Wong NW; Chong CS; Foo FJ; Chan WPW
    J Dig Dis; 2021 Jul; 22(7):399-407. PubMed ID: 34048153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
    Erős A; Farkas N; Hegyi P; Szabó A; Balaskó M; Veres G; Czakó L; Bajor J; Alizadeh H; Rakonczay Z; Mikó A; Habon T; Erőss B; Bérczi B; Sarlós P
    Dig Liver Dis; 2019 Aug; 51(8):1086-1095. PubMed ID: 31278016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
    Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
    Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Prevention of Postoperative Recurrence in Crohn's Disease.
    Vuitton L; Peyrin-Biroulet L
    Drugs; 2020 Mar; 80(4):385-399. PubMed ID: 32056142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
    de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
    Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
    Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
    Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.